KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$24.43
+0.33%Sep 14, 2026, 20:01 UTC
Kestra Medical Technologies, Ltd. reported financial results for the first quarter of fiscal year 2027, ended July 31, 2026.
Source:Sep 11, 2026, 01:49 UTC
Jeffrey Lawrence Schwartz, a Director and 10% Owner of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), sold 3,890 common shares for about $97,942 on September 8, 2026 to cover tax withholding obligations tied to restricted stock unit vesting.
Source:Sep 10, 2026, 10:00 UTC
Kestra Medical Technologies named Daniel Finney Vice President of Research & Development and appointed him to its executive leadership team.
Source:Aug 31, 2026, 20:01 UTC
Kestra Medical Technologies announced it will report its first quarter fiscal 2027 financial results after market close on September 14, 2026.
Jul 14, 2026, 22:03 UTC
Kestra Medical Technologies reported its fourth-quarter financial results, showing a sharp increase in revenue.
Source:Jul 14, 2026, 20:05 UTC
Kestra Medical Technologies entered into a five-year term loan facility with funds managed by Pharmakon Advisors, LP for up to $200 million.
Source:Jul 14, 2026, 00:00 UTC
Kestra Medical Technologies signed a five-year $200 million senior secured term loan facility, with $75 million Tranche A funded at closing and proceeds used for general corporate needs and repayment of prior debt.